These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 35422475)

  • 1. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
    Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
    Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
    Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
    J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FTO facilitates cancer metastasis by modifying the m
    Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
    Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m
    Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
    Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN/PI3K/AKT pathway.
    Lin K; Zhou E; Shi T; Zhang S; Zhang J; Zheng Z; Pan Y; Gao W; Yu Y
    J Exp Clin Cancer Res; 2023 Aug; 42(1):217. PubMed ID: 37605223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma.
    Wang F; Liao Y; Zhang M; Zhu Y; Wang W; Cai H; Liang J; Song F; Hou C; Huang S; Zhang Y; Wang C; Hou J
    Oncogene; 2021 Jun; 40(22):3885-3898. PubMed ID: 33972683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2.
    Wang F; Hu Y; Wang H; Hu P; Xiong H; Zeng Z; Han S; Wang D; Wang J; Zhao Y; Huang Y; Zhuo W; Lv G; Zhao G
    J Exp Clin Cancer Res; 2023 Oct; 42(1):267. PubMed ID: 37840133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m
    Wang W; He Y; Zhai LL; Chen LJ; Yao LC; Wu L; Tang ZG; Ning JZ
    Epigenetics; 2022 Dec; 17(12):1738-1752. PubMed ID: 35404184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m
    Xu A; Zhang J; Zuo L; Yan H; Chen L; Zhao F; Fan F; Xu J; Zhang B; Zhang Y; Yin X; Cheng Q; Gao S; Deng J; Mei H; Huang Z; Sun C; Hu Y
    Mol Ther; 2022 Mar; 30(3):1104-1118. PubMed ID: 34915192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FTO regulates myoblast proliferation by controlling CCND1 expression in an m
    Deng K; Zhang Z; Ren C; Liang Y; Gao X; Fan Y; Wang F
    Exp Cell Res; 2021 Apr; 401(2):112524. PubMed ID: 33651996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin gallate targets FTO and inhibits adipogenesis in an mRNA m
    Wu R; Yao Y; Jiang Q; Cai M; Liu Q; Wang Y; Wang X
    Int J Obes (Lond); 2018 Jul; 42(7):1378-1388. PubMed ID: 29795461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
    Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G
    Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FTO elicits tumor neovascularization in cancer-associated fibroblasts through eliminating m
    Liao Q; Shi H; Yang J; Ge S; Jia R; Song X; Chai P; Jia R
    Cancer Lett; 2024 Jun; 592():216911. PubMed ID: 38685450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
    Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
    Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FTO up-regulation induced by MYC suppresses tumour progression in Epstein-Barr virus-associated gastric cancer.
    Xu YY; Li T; Shen A; Bao XQ; Lin JF; Guo LZ; Meng Q; Ruan DY; Zhang QH; Zuo ZX; Zeng ZL
    Clin Transl Med; 2023 Dec; 13(12):e1505. PubMed ID: 38082402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTO regulates adipogenesis by controlling cell cycle progression via m
    Wu R; Liu Y; Yao Y; Zhao Y; Bi Z; Jiang Q; Liu Q; Cai M; Wang F; Wang Y; Wang X
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1323-1330. PubMed ID: 30305247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway.
    Zhang L; Wan Y; Zhang Z; Jiang Y; Lang J; Cheng W; Zhu L
    RNA Biol; 2021 Sep; 18(9):1265-1278. PubMed ID: 33103587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTO-Dependent
    Huang H; Wang Y; Kandpal M; Zhao G; Cardenas H; Ji Y; Chaparala A; Tanner EJ; Chen J; Davuluri RV; Matei D
    Cancer Res; 2020 Aug; 80(16):3200-3214. PubMed ID: 32606006
    [No Abstract]   [Full Text] [Related]  

  • 20. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.